000 | 01583 a2200421 4500 | ||
---|---|---|---|
005 | 20250513204803.0 | ||
264 | 0 | _c20000421 | |
008 | 200004s 0 0 eng d | ||
022 | _a0022-3565 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKrowicki, Z K | |
245 | 0 | 0 |
_aSubstance P in the dorsal motor nucleus of the vagus evokes gastric motor inhibition via neurokinin 1 receptor in rat. _h[electronic resource] |
260 |
_bThe Journal of pharmacology and experimental therapeutics _cApr 2000 |
||
300 |
_a214-21 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aGanglionic Blockers _xpharmacology |
650 | 0 | 4 |
_aGastric Fundus _xdrug effects |
650 | 0 | 4 |
_aGastrointestinal Motility _xdrug effects |
650 | 0 | 4 |
_aHemodynamics _xdrug effects |
650 | 0 | 4 |
_aHexamethonium _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMicroinjections |
650 | 0 | 4 |
_aMotor Neurons _xdrug effects |
650 | 0 | 4 |
_aNeural Pathways _xdrug effects |
650 | 0 | 4 | _aNeurokinin-1 Receptor Antagonists |
650 | 0 | 4 |
_aNitric Oxide _xphysiology |
650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
650 | 0 | 4 | _aNitric Oxide Synthase Type II |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptors, Neurokinin-1 _xagonists |
650 | 0 | 4 |
_aSubstance P _xadministration & dosage |
650 | 0 | 4 | _aVagotomy |
650 | 0 | 4 |
_aVagus Nerve _xdrug effects |
700 | 1 | _aHornby, P J | |
773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 293 _gno. 1 _gp. 214-21 |
|
999 |
_c10687712 _d10687712 |